Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02998229 · ClinicalTrials.gov registry record · NA

The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).

A NA study of Intracranial Aneurysm, sponsored by Medtronic Neurovascular Clinical Affairs.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
19
Study locations

NCT02998229 is a NA study of Intracranial Aneurysm that is actively recruiting participants, run by Medtronic Neurovascular Clinical Affairs. The registered enrollment target is 300 participants, below the 9,175-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (97% lower). The trial reports 19 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02998229, a NA study of Intracranial Aneurysm, is actively recruiting participants, sponsored by Medtronic Neurovascular Clinical Affairs.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
19
Study locations

Study Summary

The purpose of this study is to assess the safety and effectiveness of the Artisse™ Intrasaccular Device in the treatment of unruptured and ruptured wide-neck bifurcating intracranial aneurysms.

Conditions Studied

Intracranial Aneurysm

Interventions

  • DEVICE Artisse™ Intrasaccular Device

Study Locations (19)

New York

  • Albany Medical Center - Albany
  • Buffalo General Medical Center - Buffalo
  • The Mount Sinai Hospital - New York
  • Stony Brook University Hospital - Stony Brook

Pennsylvania

  • Hospital of the University of Pennsylvania - Philadelphia
  • Thomas Jefferson University Hospital - Philadelphia
  • UPMC Presbyterian - Pittsburgh

Florida

  • Baptist Medical Center Jacksonville - Jacksonville
  • Tampa General Hospital - Tampa

Illinois

  • University of Chicago - Chicago
  • Advocate Lutheran General Hospital - Park Ridge

Connecticut

  • Yale New Haven Hospital - New Haven

Iowa

  • University of Iowa Hospitals and Clinics - Iowa City

North Carolina

  • Novant Health Brain and Spine Surgery - Charlotte

Ohio

  • Cleveland Clinic Foundation - Cleveland

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2024-04-16
Est. Completion 2032-02
Phase NA

Sponsor

Medtronic Neurovascular Clinical Affairs

20 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02998229

The ClinicalTrials.gov registry entry for NCT02998229 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,175-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (97% lower). The listed sponsor is Medtronic Neurovascular Clinical Affairs, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Intracranial Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Artisse™ Intrasaccular Device is the first listed.

NCT02998229 reports 19 study locations spanning 12 distinct geographic areas - top geographies include New York, Pennsylvania, Florida.

Frequently Asked Questions

What is clinical trial NCT02998229 about?

NCT02998229 is a clinical study titled "The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).". The purpose of this study is to assess the safety and effectiveness of the Artisse™ Intrasaccular Device in the treatment of unruptured and ruptured wide-neck bifurcating intracranial aneurysms.

What is the current status of trial NCT02998229?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-04-16. Estimated completion is 2032-02.

What conditions does trial NCT02998229 study?

This clinical trial studies the following conditions: Intracranial Aneurysm.

What interventions are being tested in trial NCT02998229?

The interventions under investigation include: Artisse™ Intrasaccular Device (DEVICE).

Who is sponsoring clinical trial NCT02998229?

This trial is sponsored by Medtronic Neurovascular Clinical Affairs, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02998229 being conducted?

This trial has 19 study locations across Connecticut, Florida, Illinois, Iowa, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Intracranial Aneurysm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Intracranial Aneurysm

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.